skip to main content

December 4, 2020. 4:30 – 9:00 pm (Doha time) / 8:30 am – 1:00 pm (ET)


A Catalyst for Change: Promoting Health Equity in Global Medical Education in the Post COVID-19 Era

Accreditation

QCHP

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Qatar Council for Healthcare Practitioners (QCHP) of the Ministry of Public Health.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners-Accreditation Department and is approved for a maximum of 3.75 hours.

 

ACCME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Weill Cornell Medicine-Qatar and Association of American Medical Colleges.

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

 

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Qatar Council for Healthcare Practitioners (QCHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Thurayya Arayssi, MD, Janette Samaan, PhD, Deema Al-Sheikhly, MRes, Adriane Lopez, Bruno Mourao Pacheco, Medical Student, Dana A-Ali, Medical Student, Sumeja Zahirovic, MD, Julie Youm, PhD, Jamunarani S, PhD, Houry Puzantian, PhD, Janet Hafler, PhD, Angela Requena, MPH, Nathan Bertelsen, MD, Alcyr Oliveira, PhD, Phyllis Muffuh Navti, DHSci, Moune Jabre, MD, Douglas Bovell, PhD, Amine Rakab, MD, Abebe Bekele, MD have no relevant financial relashionship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Course Directors: Thurrayya Arayssi, MD, Janette Samaan, PhD

Have no relevant financial relationship to disclose

Will not be discussing any unlabeled/unapproved use of drugs or products

Administrative Contact: Ameena Abdul Rahim, MSc

Has no relevant financial relationship to disclose

Will not be discussing any unlabeled/unapproved use of drugs or products

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.